Recent Advances in Hepatitis C Virus Treatment: Review of HCV Protease Inhibitor Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|5|3|158-173

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.5, Iss.3, 2010-09, pp. : 158-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C Virus (HCV)

By  

Transfusion Medicine and Hemotherapy, Vol. 32, Iss. 3-4, 2005-08 ,pp. : 184-195

Karger

Access to resources Recommend Favorite

Hepatitis C Virus (HCV)

By  

Transfusion Medicine and Hemotherapy, Vol. 30, Iss. 5, 2003-10 ,pp. : 239-250

Karger

Access to resources Recommend Favorite

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

By Karasik Avraham   Aschner Pablo   Katzeff Harvey   Davies Michael J.   Stein Peter P.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 489-496

Informa Healthcare

Access to resources Recommend Favorite

Organic Anion Transporting Polypeptide‐Mediated Transport of, and Inhibition by, Asunaprevir, an Inhibitor of Hepatitis C Virus NS3 Protease

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 159-166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 4, 2015-04 ,pp. : 467-477

John Wiley & Sons Inc

Access to resources Recommend Favorite